Pham Quang X 4
4 · Cadrenal Therapeutics, Inc. · Filed Jan 19, 2024
Insider Transaction Report
Form 4
Pham Quang X
DirectorCEO and Chairman10% Owner
Transactions
- Award
Stock Options
2024-01-18+150,000→ 150,000 totalExercise: $0.94Exp: 2034-01-17→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]These options vest 25% on February 1, 2025 and thereafter pro rata on a monthly basis for the next 36 months.